Combination Antihypertensive Therapy Prescribing and Blood Pressure Control in a Real-World Setting
نویسندگان
چکیده
منابع مشابه
Central blood pressure measurements and antihypertensive therapy: a consensus document.
The 2003 European Society of Hypertension/European Society of Cardiology guidelines for the management of arterial hypertension1 included 2 important novel recommendations: assessment of the total cardiovascular risk should be taken into account in the management of the hypertensive patient, and quantification of risk should include subclinical target organ damage. These guidelines acknowledged...
متن کاملAzilsartan/chlorthalidone combination therapy for blood pressure control
BACKGROUND Edarbyclor(®) is a combined angiotensin receptor blocker (ARB) and thiazide-like diuretic (azilsartan and chlorthalidone), and was approved on December 20, 2011 by the US Food and Drug Administration (FDA) for hypertension management. OBJECTIVE To review the pharmacology, pharmacokinetics, efficacy, safety, tolerability, and role of azilsartan plus chlorthalidone for hypertension m...
متن کاملCombination Therapy in Antihypertensive Treatment
One of the most prevalent and important disease worldwide is arterial hypertension with prevalence of 35-40%. When we look worldwide prevalence of hypertension in 2000, we can see that approximately 972 millions of people were with hypertension, and the estimation is that around 1560 millions of people in 2025 will have hypertension [1]. There is a linear association between increased blood pre...
متن کاملTiming of antihypertensive therapy and circadian blood pressure pattern.
Timing of Antihypertensive Therapy and Circadian Blood Pressure Pattern To the Editor: We read with great interest the recent article by de la Sierra et al1 about the prevalence and factors associated with circadian blood pressure patterns in a huge population of 42 947 hypertensive patients studied with 24-hour ambulatory blood pressure monitoring. Their cross-sectional study shows an associat...
متن کاملAntihypertensive Drug Therapy in Consideration of Circadian Blood Pressure Variation*
J-MUBA was a large-scale clinical study which, for the first time in the world, evaluated the effects of an antihypertensive drug on circadian BP variation in more than 600 patients with hypertension. Although ACE inhibitors reportedly exert equal 24-hour antihypertensive effects on daytime and nighttime BP, and -blockers are reported to have weaker effects on nighttime BP than on daytime BP. H...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: American Journal of Hypertension
سال: 2019
ISSN: 0895-7061,1941-7225
DOI: 10.1093/ajh/hpz196